Emmes can help you navigate the investigational new drug, device and biologics regulatory pathways toward a successful product launch.

We understand how drug and medical device regulations impact your product regulatory approval timelines.

We know the unique challenges clinical studies of maternal and pediatric populations present.

We understand the physiological and ethical reasons for these challenges, and the diverse and discrete issues, and we are skilled in the nuances of this patient group. So our solutions in study design and implementation deliver high quality results acceptable to regulatory agencies and prominent journals.

Wherever health challenges arise, Emmes Group is there, advancing science, accelerating innovation, and making a difference worldwide.

At Emmes Group, we bring People, Science, and Technology together to deliver meaningful, measurable impact on global health.

At Emmes Group, we are proud to serve a global network of clients who share a commitment to advancing health through high-integrity research. From biopharmaceutical innovators and federal agencies to academic centers, non-profits, and foundations, our partners rely on us to bring science, strategy, and operational strength to their most important work.

With a long history of advancing hematology research, we’re your partner in the rapidly changing world of hematopoietic stem cell transplantation (HSCT) and cellular and gene therapies.

We’re particularly proud to have partnered with a client to successfully run Phase I and Phase II trials, establishing dosing and proof of concept for a compound with the potential to become the first bone marrow transplant product to receive Breakthrough Therapy Designation from the U.S.

With a foundation built on decades of research and collaboration with leading investigators, our Cell and Gene Therapy team brings more than 45 years of invaluable expertise in conducting clinical trials to our customers.

Our innovations are unlocking real research potential to test and create life-changing treatments for patients suffering from a wide range of conditions and diseases.

Through the knowledge of our leadership team, Emmes Group envisions a future where clinical research is not only advanced, but transformed. We strive to be at the forefront of scientific discovery, pioneering new ways to integrate technology, AI and human expertise for the betterment of healthcare worldwide. Together we are committed to fostering innovation, scientific excellence, and the seamless integration of technology into the fabric of clinical research.

Ophthalmology

Our innovative therapeutic solutions have already improved the lives of millions.